The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
| Autor: | Fatma Sena Dost Günay, Neziha Erken, Ahmet Turan Isik, Pinar Soysal |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Pediatrics
medicine.medical_specialty Activities of daily living business.industry medicine.medical_treatment Cancer therapy Cancer Anastrozole Cognition General Medicine medicine.disease Radiation therapy 03 medical and health sciences 0302 clinical medicine Breast cancer medicine 030212 general & internal medicine Geriatrics and Gerontology business Cognitive impairment 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Clinical Interventions in Aging. 15:691-693 |
| ISSN: | 1178-1998 |
| DOI: | 10.2147/cia.s252229 |
| Popis: | Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|